Clinical trial
Phase 1 Trial of Oral Karenitecin® in Patients With Solid Tumors"
NCT00097903 is registered in ClinicalTrials.gov with BioNumerik Pharmaceuticals, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 1 Trial of Oral Karenitecin® in Patients With Solid Tumors"
- Lead sponsor
- BioNumerik Pharmaceuticals, Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- May 31, 2004
- Completion date
- May 31, 2013
- Enrollment
- 32 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.